The five-year survival rate of patients with stage IIIa moderately differentiated adenocarcinoma of the stomach is about 30% after surgery and other treatments, which can vary.
Gastric cancer is a common malignant tumor of the digestive system, which can be caused by various factors such as heredity and Helicobacter pylori infection. According to the clinical staging of the tumor, stage IIIa is the middle to late stage of the disease, which represents the tumor infiltrating into the intrinsic muscle layer, more than seven lymph nodes metastasis, no distant metastasis and other conditions.
If there is a chance of surgery in this period, surgical treatment is feasible, followed by radiotherapy, chemotherapy, targeted therapy and other therapies. After active treatment, the five-year survival rate of patients in this period is about 30%. After treatment, patients should follow the doctor’s instructions for regular review in order to reduce the recurrence rate and prolong the survival period.